메뉴 건너뛰기




Volumn 9, Issue 1, 2007, Pages 39-49

Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats

Author keywords

5 endorphin; Angiotensin; Opioid receptors; Phosphoenolpyruvate carboxykinase; Streptozotocin induced diabetic rats; Subtype 4 form of glucose transporter; Valsartan

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN 1 RECEPTOR; BETA ENDORPHIN; CHOLINERGIC RECEPTOR; GLUCOSE; GLUCOSE OXIDASE; GLUCOSE TRANSPORTER 4; MESSENGER RNA; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALOXONAZINE; NALOXONE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); STREPTOZOCIN; VALSARTAN;

EID: 33845543316     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2005.00566.x     Document Type: Article
Times cited : (11)

References (40)
  • 1
    • 33749230793 scopus 로고    scopus 로고
    • The role of angiotensin II in hypertension and end-organ damage
    • Pool JL. The role of angiotensin II in hypertension and end-organ damage. Int J Clin Pract Suppl 2000; 111: 4-8.
    • (2000) Int J Clin Pract Suppl , vol.111 , pp. 4-8
    • Pool, J.L.1
  • 2
    • 0034088314 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension
    • Israili ZH. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension. J Hum Hypertens 2000; 14: S73-S86.
    • (2000) J Hum Hypertens , vol.14
    • Israili, Z.H.1
  • 3
    • 0034685168 scopus 로고    scopus 로고
    • Angiotensin II receptor antagonists
    • Burnier M, Brunner HR. Angiotensin II receptor antagonists. Lancet 2000; 355: 637-645.
    • (2000) Lancet , vol.355 , pp. 637-645
    • Burnier, M.1    Brunner, H.R.2
  • 4
    • 25844476905 scopus 로고    scopus 로고
    • Angiotensin receptor blockers: Therapeutic targets and cardiovascular protection
    • Ruilope LM, Rosei EA, Bakris GL et al. Angiotensin receptor blockers: therapeutic targets and cardiovascular protection. Blood Press 2005; 14: 196-209.
    • (2005) Blood Press , vol.14 , pp. 196-209
    • Ruilope, L.M.1    Rosei, E.A.2    Bakris, G.L.3
  • 6
    • 0035724736 scopus 로고    scopus 로고
    • Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats
    • Henriksen EJ, Jacob S, Kinnick TR, Teachey MK, Krekler M. Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension 2001; 38: 884-890.
    • (2001) Hypertension , vol.38 , pp. 884-890
    • Henriksen, E.J.1    Jacob, S.2    Kinnick, T.R.3    Teachey, M.K.4    Krekler, M.5
  • 7
    • 3242706039 scopus 로고    scopus 로고
    • Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats
    • Ran J, Hirano T, Adachi M. Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats. Am J Physiol Endocrinol Metab 2004; 287: E227-E232.
    • (2004) Am J Physiol Endocrinol Metab , vol.287
    • Ran, J.1    Hirano, T.2    Adachi, M.3
  • 8
    • 0002550360 scopus 로고    scopus 로고
    • Paracrine effects of angiotensin-converting enzyme and angiotensin-II-receptor inhibition on transcapillary glucose transport in humans
    • Frossard M, Joukhadar C, Steffen G, Schmid R, Eichler HG, Muller M. Paracrine effects of angiotensin-converting enzyme and angiotensin-II-receptor inhibition on transcapillary glucose transport in humans. Life Sci 2000; 66: PL147-PL154.
    • (2000) Life Sci , vol.66
    • Frossard, M.1    Joukhadar, C.2    Steffen, G.3    Schmid, R.4    Eichler, H.G.5    Muller, M.6
  • 9
    • 24644510705 scopus 로고    scopus 로고
    • HOPE/HOPE-TOO Study Investigators. Long-term effects of ramipril on cardiovascular events and on diabetes: Results of the HOPE study extension
    • Bosch J, Lonn E, Pogue J, Arnold JM, Dagenais GR, Yusuf S. HOPE/HOPE-TOO Study Investigators. Long-term effects of ramipril on cardiovascular events and on diabetes: Results of the HOPE study extension. Circulation 2005; 112: 1339-1346.
    • (2005) Circulation , vol.112 , pp. 1339-1346
    • Bosch, J.1    Lonn, E.2    Pogue, J.3    Arnold, J.M.4    Dagenais, G.R.5    Yusuf, S.6
  • 11
    • 0034740517 scopus 로고    scopus 로고
    • Pharmacology of AT1-receptor blockers
    • Unger T. Pharmacology of AT1-receptor blockers. Blood Press Suppl 2001; 3: 5-10.
    • (2001) Blood Press Suppl , vol.3 , pp. 5-10
    • Unger, T.1
  • 12
    • 10444283441 scopus 로고    scopus 로고
    • Therapeutic effects of angiotensin (AT1) receptor antagonists: Potential contribution of mechanisms other than AT1 receptor blockade
    • Schmidt B, Drexler H, Schieffer B. Therapeutic effects of angiotensin (AT1) receptor antagonists: Potential contribution of mechanisms other than AT1 receptor blockade. Am J Cardiovasc Drugs 2004; 4: 361-368.
    • (2004) Am J Cardiovasc Drugs , vol.4 , pp. 361-368
    • Schmidt, B.1    Drexler, H.2    Schieffer, B.3
  • 13
    • 20844457604 scopus 로고    scopus 로고
    • Valsartan in elderly isolated systolic hypertension (VALISH) study: Rationale and design
    • Ogihara T, Saruta T, Matsuoka H et al. Valsartan in elderly isolated systolic hypertension (VALISH) study: Rationale and design. Hypertens Res 2004; 27: 657-661.
    • (2004) Hypertens Res , vol.27 , pp. 657-661
    • Ogihara, T.1    Saruta, T.2    Matsuoka, H.3
  • 14
    • 13944258929 scopus 로고    scopus 로고
    • Valsartan in chronic heart failure
    • Ripley TL. Valsartan in chronic heart failure. Ann Pharmacother 2005; 39: 460-469.
    • (2005) Ann Pharmacother , vol.39 , pp. 460-469
    • Ripley, T.L.1
  • 15
    • 0037880398 scopus 로고    scopus 로고
    • Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats
    • Chan P, Wong KL, Liu IM, Tzeng TF, Yang TL, Cheng JT. Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats. J Hypertens 2003; 21: 761-769.
    • (2003) J Hypertens , vol.21 , pp. 761-769
    • Chan, P.1    Wong, K.L.2    Liu, I.M.3    Tzeng, T.F.4    Yang, T.L.5    Cheng, J.T.6
  • 17
    • 0028971924 scopus 로고
    • Plasma levels of beta-endorphin, leucine enkephalin and arginine vasopressin in patients with essential hypertension and the effects of clonidine
    • Zheng X, Zhang T, Ding H, Wang C. Plasma levels of beta-endorphin, leucine enkephalin and arginine vasopressin in patients with essential hypertension and the effects of clonidine. Int J Cardiol 1995; 51: 233-244.
    • (1995) Int J Cardiol , vol.51 , pp. 233-244
    • Zheng, X.1    Zhang, T.2    Ding, H.3    Wang, C.4
  • 18
    • 0025140981 scopus 로고
    • Effects of an angiotensin converting enzyme (ACE) inhibitor on plasma endorphin level
    • Kaada B, Woie L. Effects of an angiotensin converting enzyme (ACE) inhibitor on plasma endorphin level. Gen Pharmacol 1990; 21: 693-695.
    • (1990) Gen Pharmacol , vol.21 , pp. 693-695
    • Kaada, B.1    Woie, L.2
  • 19
    • 0035650637 scopus 로고    scopus 로고
    • Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats
    • Cheng JT, Liu IM, Chi TC, Tzeng TF, Lu FH, Chang CJ. Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes 2001; 50: 2815-2821.
    • (2001) Diabetes , vol.50 , pp. 2815-2821
    • Cheng, J.T.1    Liu, I.M.2    Chi, T.C.3    Tzeng, T.F.4    Lu, F.H.5    Chang, C.J.6
  • 20
    • 0036810873 scopus 로고    scopus 로고
    • Plasma glucose-lowering effect of beta-endorphin in streptozotocin-induced diabetic rats
    • Cheng JT, Liu IM, Tzeng TF, Tsai CC, Lai TY. Plasma glucose-lowering effect of beta-endorphin in streptozotocin-induced diabetic rats. Horm Metab Res 2002; 34: 570-576.
    • (2002) Horm Metab Res , vol.34 , pp. 570-576
    • Cheng, J.T.1    Liu, I.M.2    Tzeng, T.F.3    Tsai, C.C.4    Lai, T.Y.5
  • 21
    • 0032031040 scopus 로고    scopus 로고
    • Opioid μ receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality
    • Loh HH, Liu HC, Cavalli A, Yang W, Chen YF, Wei LN. Opioid μ receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res 1998; 54: 321-326.
    • (1998) Brain Res Mol Brain Res , vol.54 , pp. 321-326
    • Loh, H.H.1    Liu, H.C.2    Cavalli, A.3    Yang, W.4    Chen, Y.F.5    Wei, L.N.6
  • 22
    • 0035854604 scopus 로고    scopus 로고
    • Loss of plasma glucose lowering response to cold stress in opioid mu-receptor knock-out diabetic mice
    • Liu IM, Chi TC, Shiao GC, Lin MT, Cheng JT. Loss of plasma glucose lowering response to cold stress in opioid mu-receptor knock-out diabetic mice. Neurosci Lett 2001; 307: 81-84.
    • (2001) Neurosci Lett , vol.307 , pp. 81-84
    • Liu, I.M.1    Chi, T.C.2    Shiao, G.C.3    Lin, M.T.4    Cheng, J.T.5
  • 23
    • 0035829017 scopus 로고    scopus 로고
    • Stimulatory effect of phenylephrine on the secretion of β-endorphin from rat adrenal medulla in vitro
    • Cheng JT, Liu IM, Kuo DH, Lin MT. Stimulatory effect of phenylephrine on the secretion of β-endorphin from rat adrenal medulla in vitro. Auton Neurosci Basic Clin 2001; 93: 31-35.
    • (2001) Auton Neurosci Basic Clin , vol.93 , pp. 31-35
    • Cheng, J.T.1    Liu, I.M.2    Kuo, D.H.3    Lin, M.T.4
  • 24
    • 0344736999 scopus 로고    scopus 로고
    • Mediation of beta-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats
    • Liu IM, Chen WC, Cheng JT. Mediation of beta-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 2003; 307: 1196-1204.
    • (2003) J Pharmacol Exp Ther , vol.307 , pp. 1196-1204
    • Liu, I.M.1    Chen, W.C.2    Cheng, J.T.3
  • 25
    • 0023576328 scopus 로고
    • Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Effect of insulin treatment
    • Wohaieb SA, Godin DV. Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Effect of insulin treatment. Diabetes 1987; 36: 1014-1018.
    • (1987) Diabetes , vol.36 , pp. 1014-1018
    • Wohaieb, S.A.1    Godin, D.V.2
  • 26
    • 20144373685 scopus 로고    scopus 로고
    • Review of exercise in prevention of diabetes
    • Ishida T. Review of exercise in prevention of diabetes. Nippon Rinsho 2005; 63 (S2): 513-516.
    • (2005) Nippon Rinsho , vol.63 , Issue.S2 , pp. 513-516
    • Ishida, T.1
  • 27
    • 0017737881 scopus 로고
    • β-endorphin and adrenal corticotropin are secreted concomitantly by the pituitary gland
    • Vargo T, Rossier J, Minick S et al. β-endorphin and adrenal corticotropin are secreted concomitantly by the pituitary gland. Science 1977; 197: 1367-1369.
    • (1977) Science , vol.197 , pp. 1367-1369
    • Vargo, T.1    Rossier, J.2    Minick, S.3
  • 28
    • 0022701732 scopus 로고
    • Detection of the pro-opiomelanocortin peptide fragments-beta-endorphin and ACTH-in the adrenals of rats and mice by immunohistochemistry
    • Arefolov VA, Dmitriev AD, Tennov AV, Val'dman AV. Detection of the pro-opiomelanocortin peptide fragments-beta-endorphin and ACTH-in the adrenals of rats and mice by immunohistochemistry. Biull Eksp Biol Med 1986; 101: 445-447.
    • (1986) Biull Eksp Biol Med , vol.101 , pp. 445-447
    • Arefolov, V.A.1    Dmitriev, A.D.2    Tennov, A.V.3    Val'dman, A.V.4
  • 29
    • 0022340458 scopus 로고
    • In vivo and in vitro effects of angiotensin II on the release of beta-endorphin-like immunoreactivity
    • Matsumura M, Inoue S, Yamanoi A, Chikamori K, Saito S. In vivo and in vitro effects of angiotensin II on the release of beta-endorphin-like immunoreactivity. Endocrinol Jpn 1985; 32: 233-240.
    • (1985) Endocrinol Jpn , vol.32 , pp. 233-240
    • Matsumura, M.1    Inoue, S.2    Yamanoi, A.3    Chikamori, K.4    Saito, S.5
  • 30
    • 0020332878 scopus 로고
    • [Met5]-enkephalin-like peptides of the adrenal medulla: Release by nerve stimulation and functional implications
    • Hanbauer I, Kelly GD, Saiani L, Yang HY. [Met5]-enkephalin-like peptides of the adrenal medulla: Release by nerve stimulation and functional implications. Peptides 1982; 3: 469-473.
    • (1982) Peptides , vol.3 , pp. 469-473
    • Hanbauer, I.1    Kelly, G.D.2    Saiani, L.3    Yang, H.Y.4
  • 31
    • 0024495845 scopus 로고
    • Stimulation of cholinergic receptor mediated secretion from the bovine adrenal medulla by neuropeptide Y
    • Hexum TD, Russett LR. Stimulation of cholinergic receptor mediated secretion from the bovine adrenal medulla by neuropeptide Y. Neuropeptides 1989; 13: 35-41.
    • (1989) Neuropeptides , vol.13 , pp. 35-41
    • Hexum, T.D.1    Russett, L.R.2
  • 32
    • 0026446055 scopus 로고
    • Protein kinase C activators stimulate beta-endorphin secretion from hypothalamic cells
    • Kapcala LP, Weng CF, Juang HH. Protein kinase C activators stimulate beta-endorphin secretion from hypothalamic cells. Brain Res Bull 1992; 29: 553-557.
    • (1992) Brain Res Bull , vol.29 , pp. 553-557
    • Kapcala, L.P.1    Weng, C.F.2    Juang, H.H.3
  • 33
    • 16344367289 scopus 로고    scopus 로고
    • Advances in opioid pharmacology
    • Gourlay GK. Advances in opioid pharmacology. Support Care Cancer 2005; 13: 153-159.
    • (2005) Support Care Cancer , vol.13 , pp. 153-159
    • Gourlay, G.K.1
  • 34
    • 0024215058 scopus 로고
    • Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats
    • Ziel FH, Venkatesan N, Davidson MB. Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes 1988; 37: 885-890.
    • (1988) Diabetes , vol.37 , pp. 885-890
    • Ziel, F.H.1    Venkatesan, N.2    Davidson, M.B.3
  • 35
    • 0026607990 scopus 로고
    • Mammalian facilitative glucose transporter family: Structure and molecular regulation
    • Pessin JE, Bell GI. Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu Rev Physiol 1992; 54: 911-930.
    • (1992) Annu Rev Physiol , vol.54 , pp. 911-930
    • Pessin, J.E.1    Bell, G.I.2
  • 36
    • 20144384097 scopus 로고    scopus 로고
    • Disorder of glucose metabolism in skeletal muscle
    • Horike N, Asano T. Disorder of glucose metabolism in skeletal muscle. Nippon Rinsho 2005; 63 (S2): 136-140.
    • (2005) Nippon Rinsho , vol.63 , Issue.S2 , pp. 136-140
    • Horike, N.1    Asano, T.2
  • 37
    • 0038199736 scopus 로고    scopus 로고
    • Control of glycogen deposition
    • Ferrer JC, Favre C, Gomis RR et al. Control of glycogen deposition. FEBS Lett 2003; 546: 127-132.
    • (2003) FEBS Lett , vol.546 , pp. 127-132
    • Ferrer, J.C.1    Favre, C.2    Gomis, R.R.3
  • 38
    • 0037763823 scopus 로고    scopus 로고
    • Phosphoenolpyruvate carboxylase: Three-dimensional structure and molecular mechanisms
    • Kai Y, Matsumura H, Izui K. Phosphoenolpyruvate carboxylase: three-dimensional structure and molecular mechanisms. Arch Biochem Biophys 2003; 414: 170-179.
    • (2003) Arch Biochem Biophys , vol.414 , pp. 170-179
    • Kai, Y.1    Matsumura, H.2    Izui, K.3
  • 39
    • 9244220626 scopus 로고    scopus 로고
    • Gluconeogenesis and glycogenolysis in health and diabetes
    • Boden G. Gluconeogenesis and glycogenolysis in health and diabetes. J Investig Med 2004; 52: 375-378.
    • (2004) J Investig Med , vol.52 , pp. 375-378
    • Boden, G.1
  • 40
    • 0017108414 scopus 로고
    • Glycogen phosphorylase, glucose output and vasoconstriction in the perfused rat liver. Concentration-dependence of actions of adrenaline, vasopressin and angiotensin II
    • Hems DA, Rodrigues LM, Whitton PD. Glycogen phosphorylase, glucose output and vasoconstriction in the perfused rat liver. Concentration-dependence of actions of adrenaline, vasopressin and angiotensin II. Biochem J 1976; 160: 367-374.
    • (1976) Biochem J , vol.160 , pp. 367-374
    • Hems, D.A.1    Rodrigues, L.M.2    Whitton, P.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.